Resources

MDoutlook® Delivers Precision Intelligence

MDoutlook is growing and is looking for qualified Global Medical Analysts to join our enthusiastic team of disease experts. You can review the job posting here. Direct your resume and cover letter to [email protected] (only candidates; no recruiters please). Looking forward to hearing from you.
Read more
MDoutlook continues delivering timely post-conference insight through the Post-SABCS2014 OncoPoll™ - but with a new dimension this year. The syndicated MDoutlook post-SABCS2014 analysis focuses on breast cancer therapeutic areas where much new data was presented: new agents, adjuvant & metastatic therapy, and the emerging likelihood of biosimilars used for supportive
Read more
MDoutlook continues its tradition of delivering timely post-conference insight through a series of 3 Post-ASH OncoPolls™ - but with a new dimension. The syndicated MDoutlook post-ASH2014 analysis focuses on three disease areas where much new data was presented (CLL and ALL, as well as Multiple Myeloma). To insure timely intelligence
Read more
MDoutlook is growing and is looking for qualified Global Medical Analysts to join our enthusiastic team of disease experts. You can review the job posting here. Direct your resume and cover letter to [email protected] (only candidates; no recruiters please). Looking forward to hearing from you.
Read more
MDoutlook continues delivering timely post-conference insight through the Post-SABCS2014 OncoPoll™ - but with a new dimension this year. The syndicated MDoutlook post-SABCS2014 analysis focuses on breast cancer therapeutic areas where much new data was presented: new agents, adjuvant & metastatic therapy, and the emerging likelihood of biosimilars used for supportive
Read more
MDoutlook continues its tradition of delivering timely post-conference insight through a series of 3 Post-ASH OncoPolls™ - but with a new dimension. The syndicated MDoutlook post-ASH2014 analysis focuses on three disease areas where much new data was presented (CLL and ALL, as well as Multiple Myeloma). To insure timely intelligence
Read more